Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.

Journal of gastroenterology and hepatology - 1 Jun 2014

Siddiqui Ali A, Jones Elizabeth, Andrade Darren, Shah Apeksha, Kowalski Thomas E, Loren David E, Chipitsyna Galina, Arafat Hwyda A

Abstract excerpt

BACKGROUND AND AIM: Osteopontin (OPN) is a phosphoprotein that activates pathways that induce cancer cell survival and metastasis. Our aim was to examine the expression pattern of OPN splice variants a, b, and c in fine-needle aspirates and to determine their correlation with stage-adjusted pancreatic ductal adenocarcinoma (PDA) survival. METHODS: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Endosonography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Neoplasm Metastasis

Share to Osteopontin

Share to Pancreatic Neoplasms

Share to Proportional Hazards Models

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 24548099
DOI: 10.1111/jgh.12561
PMCID: PMC4465289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.PMID 24548099Read ↗

Osteopontin Splice Variants Differentially Exert Clinicopathological Features and Biological Functions in Gastric CancerSemantic proximity Read ↗

Human osteopontin: Potential clinical applications in cancer (Review)Semantic proximity Read ↗

Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometrySemantic proximity Read ↗

Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential.Semantic proximity Read ↗

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer ProgressionSemantic proximity Read ↗

Role of osteopontin in the pathophysiology of cancerSemantic proximity Read ↗

Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell linesSemantic proximity Read ↗

The role of Osteopontin in tumor metastasis.Semantic proximity Read ↗

Role of osteopontin in cellular signaling and metastatic phenotype.Semantic proximity Read ↗

Novel prognostic markers within the CD44‐stromal ligand network in pancreatic cancerSemantic proximity Read ↗

K-ras mutation detected by peptide nucleic acid-clamping polymerase chain reaction, Ki-67, S100P, and SMAD4 expression can improve the diagnostic accuracy of inconclusive pancreatic EUS-FNB specimens.Semantic proximity Read ↗

Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.